India lowers AstraZeneca COVID-19 vaccine price for less than Rs 200 per dose
New Delhi: The Indian government has lowered the price at which it buys AstraZeneca's COVID-19 vaccine doses being produced by the Serum Institute of India (SII), the federal health secretary said on Thursday.
"The renegotiated price is significantly lower than 200 rupees ($2.75) per dose," Health Secretary Rajesh Bhushan told a news conference.
Read also: AstraZeneca COVID-19 vaccine recommended in Germany for people over 65
The SII, the world's biggest vaccine maker, has licensed the vaccine from AstraZeneca and Oxford University and markets it as COVISHIELD.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd